BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8356023)

  • 1. Influence of treatment on the maturation of the somesthetic pathway in infants with primary congenital hypothyroidism during the first year of life.
    Bongers-Schokking JJ; Colon EJ; Mulder PG; Hoogland RA; de Groot CJ; Van den Brande JL
    Pediatr Res; 1993 Jul; 34(1):73-8. PubMed ID: 8356023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatosensory evoked potentials in neonates with primary congenital hypothyroidism during the first week of therapy.
    Bongers-Schokking CJ; Colon EJ; Hoogland RA; de Groot CJ; Van den Brande JL
    Pediatr Res; 1991 Jul; 30(1):34-9. PubMed ID: 1891279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Congenital hypothyroidism. Therapeutic strategy at the early stage of treatment].
    Touati G; Léger J; Czernichow P
    Arch Fr Pediatr; 1991; 48(7):461-5. PubMed ID: 1929745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evoked potentials show early and delayed abnormalities in children with congenital hypothyroidism.
    Norcross-Nechay K; Richards GE; Cavallo A
    Neuropediatrics; 1989 Aug; 20(3):158-63. PubMed ID: 2779745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-1 and IGFBP in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G; Rapa A; Boccardo G; Silvestro L; Chiorboli E
    Minerva Endocrinol; 1999 Jun; 24(2):51-5. PubMed ID: 10941423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head circumference and linear growth during the first 3 years in treated congenital hypothyroidism in relation to aetiology and initial biochemical severity.
    Ng SM; Wong SC; Didi M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):155-9. PubMed ID: 15212659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormonal therapy of congenital hypothyroidism in childhood].
    Rondanini GF; Focarile F; Bollati A; Bianchi C
    Pediatr Med Chir; 1983; 5(6):473-6. PubMed ID: 6681055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatosensory evoked potentials in term and preterm infants in relation to postconceptional age and birth weight.
    Bongers-Schokking JJ; Colon EJ; Hoogland RA; Van den Brande JL; de Groot CJ
    Neuropediatrics; 1990 Feb; 21(1):32-6. PubMed ID: 2314556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatosensory evoked potentials and auditory brain-stem responses in congenital hypothyroidism. I. A longitudinal study before and after treatment in six infants detected in the neonatal period.
    Laureau E; Vanasse M; Hebert R; Letarte J; Glorieux J; Desjardins M; Dussault JH
    Electroencephalogr Clin Neurophysiol; 1986 Dec; 64(6):501-10. PubMed ID: 2430772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In congenital hypothyroidism, an initial L-thyroxine dose of 10-12 μg/kg/day is sufficient and sometimes excessive based on thyroid tests 1 month later.
    Vaidyanathan P; Pathak M; Kaplowitz PB
    J Pediatr Endocrinol Metab; 2012; 25(9-10):849-52. PubMed ID: 23426811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial treatment dose of L-thyroxine in congenital hypothyroidism.
    Selva KA; Mandel SH; Rien L; Sesser D; Miyahira R; Skeels M; Nelson JC; Lafranchi SH
    J Pediatr; 2002 Dec; 141(6):786-92. PubMed ID: 12461494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-thyroxine treatment in primary hypothyroidism does not increase the content of free triiodothyronine in cerebrospinal fluid: a pilot study.
    Sjöberg S; Eriksson M; Werner S; Bjellerup P; Nordin C
    Scand J Clin Lab Invest; 2011 Feb; 71(1):63-7. PubMed ID: 21214501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alpha fetoprotein in congenital hypothyroidism before and during treatment].
    Toublanc JE; Ingrand J; Megarbane M; Fulla Y; Rives S
    Arch Pediatr; 1994 Oct; 1(10):872-8. PubMed ID: 7531094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital hypothyroidism and partial thyroid hormone unresponsiveness of the pituitary in a patient with congenital thyroxine binding albumin elevation.
    Drop SL; Krenning EP; Docter R; de Muinck Keizer-Schrama SM; Visser TJ; Hennemann G
    Eur J Pediatr; 1989 Nov; 149(2):90-3. PubMed ID: 2512164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatment.
    Dubuis JM; Glorieux J; Richer F; Deal CL; Dussault JH; Van Vliet G
    J Clin Endocrinol Metab; 1996 Jan; 81(1):222-7. PubMed ID: 8550756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs.
    Peterson ME; Melián C; Nichols R
    J Am Vet Med Assoc; 1997 Dec; 211(11):1396-402. PubMed ID: 9394888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid profile of term appropriate for gestational age neonates in Nigeria: a forerunner to screening for congenital hypothyroidism.
    Adeniran KA; Okolo AA; Onyiriuka AN
    J Trop Pediatr; 2010 Oct; 56(5):329-32. PubMed ID: 20085966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypothyroxinemia in the low birth-weight infant in the screening of congenital hypothyroidism].
    Romagnoli C; Currò V; Luciano R; Zecca E; De Carolis MP; Tortorolo G; Carta Sorcini M; Tomarchio S; Alessandrini L; Fiore L
    Pediatr Med Chir; 1982; 4(6):679-84. PubMed ID: 6927422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Median nerve conduction velocity and central conduction time measured with somatosensory evoked potentials in thyroxine-treated infants with Down syndrome.
    van Trotsenburg AS; Smit BJ; Koelman JH; Dekker-van der Sloot M; Ridder JC; Tijssen JG; de Vijlder JJ; Vulsma T
    Pediatrics; 2006 Sep; 118(3):e825-32. PubMed ID: 16923926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.